loading page

Kimura’s disease treated with an anti-interleukin-5 antibody, mepolizumab: Relevance for its efficacy for the treatment of immunoglobulin G4-related diseases
  • +2
  • Manao Kinoshita,
  • Youichi Ogawa,
  • Misaki Onaka,
  • Shinji Shimada,
  • Tatsuyoshi Kawamura
Manao Kinoshita
University of Yamanashi
Author Profile
Youichi Ogawa
University of Yamanashi
Author Profile
Misaki Onaka
University of Yamanashi
Author Profile
Shinji Shimada
University of Yamanashi
Author Profile
Tatsuyoshi Kawamura
University of Yamanashi
Author Profile